Skip to content

Clinical trials

Head and Neck Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: South Korea Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20062
20083
20092
20103
20112
20121
20132
20145
20156
20162
20178
20183
20197
202010
20216
20226
20234
20247
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Active, not recruiting17
Recruiting11
Unknown status11
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University8
AstraZeneca5
Samsung Medical Center5
Seoul National University Hospital5
GlaxoSmithKline4
Eli Lilly and Company3
Hoffmann-La Roche3
ALX Oncology Inc.2
Boehringer Ingelheim2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms86
Squamous Cell Carcinoma of Head and Neck30
Carcinoma, Non-Small-Cell Lung22
Breast Neoplasms15
Colorectal Neoplasms15
Lung Neoplasms15
Neoplasms11
Ovarian Neoplasms11
Stomach Neoplasms9
Esophageal Neoplasms7

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.